Abstract:The connection of two or more proteins with different binding specificities or activities can lead to unique and powerful systems with significant potential in therapeutic applications, particularly oncology. While a plethora of active bifunctional proteins have been produced by fusion, this approach is not always viable, since modification of the N- or C- terminus can compromise the proteins’ bioactivities, with complications during folding and processing often being observed. Chemical cross-linking can offer a more versatile strategy towards the synthesis of protein-protein conjugates. However, current state-of-the-art approaches are either not selective, yielding heterogeneous mixtures or require mutations with natural or unnatural amino acids, which are often associated with low expression yields and limited applicability towards all protein systems. Recently, a bis-dibromomaleimide cross-linking reagent was used to create a bispecific scFv-Fab antibody in a site-specific manner, by targeting and bridging disulfide bonds. In this work, the application of these cross-linking reagents was extended into the conjugation of proteins containing different reactive handles, as well as sterically hindered conjugation sites. Diiodo-maleimides were shown to offer the ideal properties of rapid bioconjugation and importantly, reduced hydrolysis, which was identified as a significant factor affecting the conjugation efficiency. The optimized linkers were exploited to link human serum albumin to antibody fragments (scFv and Fab) as a prospective half-life extension platform, with retention of antigen binding and robust serum stability. The linker design was also extended to incorporate a third point of attachment for another biomolecule. An anti-CEA scFv homotrimer was formed, by disulfide bridging, which was shown to infer a combination of greater antigen avidity and increased in vivo half-life. Finally, with the view to developing a Bispecific T-cell Engager (BiTE) construct that could lead to more efficient cell-killing, an anti-CEA/ anti-CD3 scFv heterotrimer of increased avidity towards CD3 antigen was developed, showing the potential of this strategy for the construction of a diverse range of bioconjugates. The last part of this thesis describes investigations towards the development of a new methodology that selectively modifies specific lysine residues, via acyl transfer from the disulfide bond of Fab antibody fragment. This approach is expected to complement disulfide bridging as a strategy for selective modification, but also be advantageous for systems where this could result in detrimental changes to the antibody structure, offering a highly promising platform for bioconjugation.

C-Terminal Peptide Modification: Merging the Passerini Reaction with Chemo-Enzymatic Synthesis

Redox-Based Reagents for Chemoselective Methionine Bioconjugation

Selective C-Terminal Conjugation of Protease-Derived Native Peptides for Proteomic Measurements

Assembling Branched and Macrocyclic Peptides on Proteins

Late-stage C(sp2)-H and C(sp3)-H Glycosylation Ofc-Aryl/alkyl Glycopeptides: Mechanistic Insights and Fluorescence Labeling

Peptide Ligation via the Suzuki-Miyaura Cross-Coupling Reaction

A chemoenzymatic strategy for site-selective functionalization of native peptides and proteins

Selective Activation of Peptide‐Thioester Precursors for Templated Native Chemical Ligations

An Enabling Peptide Ligation Induced by Thiol‐Salicylaldehyde Ester for Chemical Protein Synthesis

A Peptide-Based Ligand-Directed Chemistry Enables Protein Functionalization

Transition-metal-catalyzed CH Functionalization for Late-Stage Modification of Peptides and Proteins

Site-selective protein modification via peptide-directed proximity catalysis

Peptide Modifications: Versatile Tools in Peptide and Natural Product Syntheses

A Sulfonium Tethered Peptide Ligand Rapidly and Selectively Modifies Protein Cysteine in Vicinity

Rapid and efficient protein synthesis through expansion of the native chemical ligation concept

Photochemically-enabled, post-translational production of C-terminal amides

Site-Selective C(sp3)–H Functionalization of Di-, Tri-, and Tetrapeptides at the N-Terminus

Two Tandem Multicomponent Reactions for the Synthesis of Sequence-Defined Polymers

Development and Recent Advances in Lysine and N-Terminal Bioconjugation for Peptides and Proteins

Expedient on-resin modification of a peptide C-terminus through a benzotriazole linker

New Strategies for Cysteine Bioconjugation and Protein Cross-Linking